ATE277924T1 - Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression - Google Patents

Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression

Info

Publication number
ATE277924T1
ATE277924T1 AT02731881T AT02731881T ATE277924T1 AT E277924 T1 ATE277924 T1 AT E277924T1 AT 02731881 T AT02731881 T AT 02731881T AT 02731881 T AT02731881 T AT 02731881T AT E277924 T1 ATE277924 T1 AT E277924T1
Authority
AT
Austria
Prior art keywords
octanes
azabicyclo
depression
aryl
treatment
Prior art date
Application number
AT02731881T
Other languages
English (en)
Inventor
Adam Matthew Gilbert
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE277924T1 publication Critical patent/ATE277924T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
AT02731881T 2001-05-25 2002-05-20 Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression ATE277924T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29356301P 2001-05-25 2001-05-25
PCT/US2002/016008 WO2002096906A1 (en) 2001-05-25 2002-05-20 Aryl-8-azabicyclo[3.2.1]octanes for the treatment of depression

Publications (1)

Publication Number Publication Date
ATE277924T1 true ATE277924T1 (de) 2004-10-15

Family

ID=23129588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02731881T ATE277924T1 (de) 2001-05-25 2002-05-20 Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression

Country Status (14)

Country Link
US (1) US6632824B2 (de)
EP (1) EP1390364B1 (de)
JP (1) JP2004533459A (de)
CN (1) CN100408575C (de)
AR (1) AR035898A1 (de)
AT (1) ATE277924T1 (de)
BR (1) BR0209995A (de)
CA (1) CA2446532A1 (de)
DE (1) DE60201440T2 (de)
DK (1) DK1390364T3 (de)
ES (1) ES2227468T3 (de)
MX (1) MXPA03010737A (de)
TW (1) TW589312B (de)
WO (1) WO2002096906A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7873566B1 (en) 2001-11-20 2011-01-18 First Data Corporation Systems and methods for selectively accessing or using financial account data for subsequent risk determination
US20030130919A1 (en) * 2001-11-20 2003-07-10 Randy Templeton Systems and methods for selectively accessing financial account information
US7668776B1 (en) 2002-01-07 2010-02-23 First Data Corporation Systems and methods for selective use of risk models to predict financial risk
US7653590B1 (en) 2002-01-14 2010-01-26 First Data Corporation System and method for overturning of risk evaluation performed by risk model to control financial risk
EP1496058A1 (de) * 2003-07-09 2005-01-12 Boehringer Ingelheim Pharma GmbH & Co.KG Neue N-(heterobicycloalkyl)-substituierte Indole oder Heteroderivate davon
ES2341489T3 (es) 2005-07-27 2010-06-21 F.Hoffmann-La Roche Ag Derivados de 4-ariloxi quinolina como moduladores de 5-ht6.
CN111217747B (zh) * 2020-03-17 2022-02-22 济南韶远医药技术有限公司 一种扑疟喹啉的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340936A (en) * 1991-02-04 1994-08-23 Hoechst-Roussel Pharmaceuticals Inc. 8-azabicyclo[3.2.1]octane methanone and corresponding oximes
US5789402A (en) 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5627196A (en) 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
IL123583A (en) 1995-10-13 2003-07-31 Neurosearch As 3-substituted -8-azabicyclo [3,2,1] oct-2-ene derivatives, their preparation and pharmaceutical compositions containing them
RU2162469C2 (ru) 1995-11-02 2001-01-27 Ньюросерч А/С Конденсированные тропановые производные в качестве ингибиторов обратного захвата нейромедиаторов
US5912256A (en) 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
AU4819099A (en) 1998-06-19 2000-01-05 Eli Lilly And Company Inhibition of serotonin reuptake
GB9815317D0 (en) * 1998-07-15 1998-09-16 Merck Sharp & Dohme Therapeutic agents
US6432976B1 (en) * 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
EP1242419A1 (de) * 1999-12-20 2002-09-25 Eli Lilly And Company Azabicyclo[3.2.1]octane derivate

Also Published As

Publication number Publication date
CN100408575C (zh) 2008-08-06
AR035898A1 (es) 2004-07-21
US6632824B2 (en) 2003-10-14
EP1390364B1 (de) 2004-09-29
DK1390364T3 (da) 2004-12-20
MXPA03010737A (es) 2004-03-02
ES2227468T3 (es) 2005-04-01
CA2446532A1 (en) 2002-12-05
EP1390364A1 (de) 2004-02-25
JP2004533459A (ja) 2004-11-04
DE60201440D1 (de) 2004-11-04
TW589312B (en) 2004-06-01
DE60201440T2 (de) 2006-02-23
BR0209995A (pt) 2004-04-06
CN1509287A (zh) 2004-06-30
US20030032645A1 (en) 2003-02-13
WO2002096906A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
ATE551340T1 (de) Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten
DE50214540D1 (de) Stanz bei der behandlung von wunden
DE69829558D1 (de) Sulfonamide für die behandlung von störungen durch endothelin vermittelt
ATE345331T1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
DE60316538D1 (de) Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen
ATE502642T1 (de) Kombinationen für die behandlung von immun- entzündlichen erkrankungen
ATE312117T1 (de) Verbindungen für die behandlung von ischämie
ATE556059T1 (de) Pyrazolderivate zur behandlung von hiv
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE60236218D1 (de) CCR5 Antagonisten verwendbar für die Behandlung von Aids
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE60325498D1 (de) 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen
DE60231107D1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE276262T1 (de) Oxazinochinolone für die behandlung viraler infektionen
DE59801385D1 (de) Durchlaufanlage für die behandlung von werkstücken
DE60130365D1 (de) Die Verwendung von Rosiglitazon zur Behandlung von psychiatrischen Erkrankungen.
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
ATE391507T1 (de) S-methyl-dihydro-ziprasidone für die behandlung von schizophrenie
DE69601154T2 (de) Zubereitungen für die Behandlung von Hepatitis C
DE60227652D1 (de) Verfahren für die herstellung von hydroxyethylaminen
DE50209798D1 (de) Substituierte 2-pyrrolidin-2-yl-1h-indol-derivative für die behandlung von migräne

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties